Literature DB >> 2782860

Penetration of cefuroxime into ventricular fluid in cerebrospinal fluid shunt infections.

M S Edwards1, C J Baker, K M Butler, E O Mason, J P Laurent, W R Cheek.   

Abstract

The penetration of intravenously administered cefuroxime into ventricular fluid was assessed in five pediatric patients with ventriculoperitoneal shunt infections and in one with a ventriculostomy infection. Patients received a total dose of 200 to 230 mg of cefuroxime per kg of body weight per day administered at 8-h intervals. Levels of cefuroxime in ventricular fluid ranged from 1.6 to 22.5 micrograms/ml and were associated with cerebrospinal fluid bactericidal titers ranging from less than 1:2 to 1:16 against infecting staphylococcal isolates. Five infections were cured with cefuroxime monotherapy. On the basis of MIC data, one patient had vancomycin substituted for cefuroxime and the infection was cured.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2782860      PMCID: PMC176071          DOI: 10.1128/AAC.33.7.1108

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

Review 3.  Cerebrospinal fluid shunt infections: a personal view.

Authors:  R Yogev
Journal:  Pediatr Infect Dis       Date:  1985 Mar-Apr

4.  Cerebrospinal fluid shunt infections. A review of 35 infections in 32 patients.

Authors:  K R Forward; H D Fewer; H G Stiver
Journal:  J Neurosurg       Date:  1983-09       Impact factor: 5.115

5.  Cerebrospinal fluid penetration of moxalactam in ventriculostomy patients.

Authors:  R J Creger; R I Cowan; H S Nearman; J L Blumer; W R Selman; L H Danziger
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

6.  The penetration of cefuroxime into the cerebrospinal fluid through inflamed and non-inflamed meninges.

Authors:  C Müller; A Netland; A F Dawson; E Andrew
Journal:  J Antimicrob Chemother       Date:  1980-03       Impact factor: 5.790

7.  Pharmacokinetics of cefuroxime in infants and children with bacterial meningitis.

Authors:  M de los A del Rio; D F Chrane; S Shelton; G H McCracken; J D Nelson
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

8.  Cefuroxime treatment of bacterial meningitis in infants and children.

Authors:  S Sirinavin; S Chiemchanya; P Visudhipan; S Lolekha
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

9.  CSF shunt infections in pediatrics. A seven-year experience.

Authors:  C Odio; G H McCracken; J D Nelson
Journal:  Am J Dis Child       Date:  1984-12

10.  Cefuroxime in bacterial meningitis.

Authors:  J Pfenninger; U B Schaad; J Lütschg; A Nussbaumer; U Zellweger
Journal:  Arch Dis Child       Date:  1982-07       Impact factor: 3.791

View more
  3 in total

Review 1.  Pharmacokinetics and tissue concentrations of cefuroxime.

Authors:  T B Vree; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1990-12-14

Review 2.  Clinical pharmacokinetics of newer cephalosporins.

Authors:  M E Klepser; M N Marangos; K B Patel; D P Nicolau; R Quintiliani; C H Nightingale
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

3.  Role of pathogenic oral flora in postoperative pneumonia following brain surgery.

Authors:  Kinga Bágyi; Angela Haczku; Ildikó Márton; Judit Szabó; Attila Gáspár; Melinda Andrási; Imre Varga; Judit Tóth; Almos Klekner
Journal:  BMC Infect Dis       Date:  2009-06-29       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.